Income Statement
Balance Sheet
Cash Flow
| Line Item | Q2 2025Apr 30, 2025 | Q1 2025Jan 31, 2025 | Q4 2024Oct 31, 2024 | Q3 2024Jul 31, 2024 |
|---|---|---|---|---|
| Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling General And Administration | 97,240 | 138,405 | 51,799 | 20,411 |
| General And Administrative Expense | 90,438 | 138,405 | 52,937 | 20,411 |
| Other Operating Expenses | 15,972 | 5,545 | 10,233 | 3,682 |
| Operating Expense | 113,212 | 143,950 | 62,032 | 24,093 |
| Operating Income | -113,212 | -143,950 | -62,032 | -24,093 |
| EBIT | -113,212 | -143,950 | -62,032 | -24,093 |
| Other Income Expense | 12,270 | 1,045 | 34,235 | -- |
| Other Non Operating Income Expenses | 8,945 | -- | 35,250 | -- |
| Gain On Sale Of Security | 3,325 | 1,045 | -1,015 | -- |
| Pretax Income | -100,942 | -142,905 | -27,797 | -24,093 |
| Tax Effect Of Unusual Items | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Continuing And Discontinued Operation | -100,942 | -142,905 | -27,798 | -24,094 |
| Net Income From Continuing Operation Net Minority Interest | -100,942 | -142,905 | -27,798 | -24,094 |
| Net Income Including Noncontrolling Interests | -100,942 | -142,905 | -27,797 | -24,093 |
| Net Income Common Stockholders | -100,942 | -142,905 | -27,798 | -24,094 |
| Net Income | -100,942 | -142,905 | -27,798 | -24,094 |
| EBITDA | -113,212 | -143,950 | -62,032 | -24,093 |
| Normalized EBITDA | -116,537 | -144,995 | -61,017 | -24,093 |
| Basic EPS | 0.00 | 0.00 | -- | 0.00 |
| Diluted EPS | 0.00 | 0.00 | -- | 0.00 |
| Basic Average Shares | 61.0M | 60.2M | -- | 52.8M |
| Diluted Average Shares | 61.0M | 60.2M | -- | 52.8M |
| Total Unusual Items | 3,325 | 1,045 | -1,015 | -- |
| Total Unusual Items Excluding Goodwill | 3,325 | 1,045 | -1,015 | -- |
| Tax Rate For Calcs | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Income | -104,267 | -143,950 | -26,783 | -24,094 |
| Diluted NI Availto Com Stockholders | -100,942 | -142,905 | -27,798 | -24,094 |
| Net Income Continuous Operations | -100,942 | -142,905 | -27,797 | -24,093 |
| Other Gand A | 82,803 | 38,370 | 23,739 | 12,776 |
| Salaries And Wages | 7,635 | 100,035 | 29,198 | 7,635 |
| Selling And Marketing Expense | 6,802 | -- | -- | 0.00 |
| Total Expenses | 113,212 | 143,950 | 62,032 | 24,093 |
| Line Item | Q2 2025Apr 30, 2025 | Q1 2025Jan 31, 2025 | Q4 2024Oct 31, 2024 | Q3 2024Jul 31, 2024 |
|---|---|---|---|---|
| Cash And Cash Equivalents | 476,861 | 56,271 | 155,012 | 72,437 |
| Cash Cash Equivalents And Short Term Investments | 476,861 | 59,346 | 157,042 | 75,482 |
| Cash Financial | 476,861 | 56,271 | 155,012 | 72,437 |
| Other Short Term Investments | 0.00 | 3,075 | 2,030 | 3,045 |
| Accounts Receivable | 28,760 | 37,603 | 23,164 | 12,400 |
| Receivables | 28,760 | 37,603 | 23,164 | 12,400 |
| Prepaid Assets | 26,793 | 7,460 | 13,207 | 0.00 |
| Other Current Assets | -- | -- | -1.00 | -- |
| Current Assets | 532,414 | 104,409 | 193,412 | 87,882 |
| Net PPE | 1.9M | 1.8M | 1.8M | 1.7M |
| Total Non Current Assets | 1.9M | 1.8M | 1.8M | 1.7M |
| Total Assets | 2.4M | 1.9M | 2.0M | 1.8M |
| Current Debt | 39,342 | 38,659 | 37,953 | 37,256 |
| Current Debt And Capital Lease Obligation | 39,342 | 38,659 | 37,953 | 37,256 |
| Payables And Accrued Expenses | 459,642 | 391,591 | 374,058 | 342,996 |
| Other Current Liabilities | 35,013 | 8,945 | 8,945 | 44,195 |
| Current Liabilities | 533,997 | 439,195 | 420,956 | 424,447 |
| Total Non Current Liabilities Net Minority Interest | 0.00 | 0.00 | 0.00 | -1.00 |
| Total Liabilities Net Minority Interest | 533,997 | 439,195 | 420,956 | 424,446 |
| Common Stock | 13.1M | 12.9M | 12.8M | 12.7M |
| Capital Stock | 13.1M | 12.9M | 12.8M | 12.7M |
| Additional Paid In Capital | 623,225 | 364,079 | 271,679 | 307,326 |
| Retained Earnings | -11.8M | -11.7M | -11.6M | -11.7M |
| Common Stock Equity | 1.9M | 1.5M | 1.5M | 1.4M |
| Stockholders Equity | 1.9M | 1.5M | 1.5M | 1.4M |
| Total Equity Gross Minority Interest | 1.9M | 1.5M | 1.5M | 1.4M |
| Total Capitalization | 1.9M | 1.5M | 1.5M | 1.4M |
| Net Tangible Assets | 1.9M | 1.5M | 1.5M | 1.4M |
| Tangible Book Value | 1.9M | 1.5M | 1.5M | 1.4M |
| Working Capital | -1,583 | -334,786 | -227,544 | -336,565 |
| Invested Capital | 1.9M | 1.5M | 1.6M | 1.4M |
| Total Debt | 39,342 | 38,659 | 37,953 | 37,256 |
| Share Issued | 69.6M | 60.3M | 59.8M | 54.6M |
| Ordinary Shares Number | 69.6M | 60.3M | 59.8M | 54.6M |
| Current Notes Payable | 39,342 | 38,659 | 37,953 | 37,256 |
| Other Equity Interest | -- | -- | -- | 10,200 |
| Line Item | Q2 2025Apr 30, 2025 | Q1 2025Jan 31, 2025 | Q4 2024Oct 31, 2024 | Q3 2024Jul 31, 2024 |
|---|---|---|---|---|
| Operating Cash Flow | -48,567 | -42,004 | -86,969 | -6,838 |
| Cash Flow From Continuing Operating Activities | -48,567 | -42,004 | -86,971 | -6,838 |
| Stock Based Compensation | 0.00 | 92,400 | -- | -- |
| Change In Working Capital | 64,645 | 9,546 | -24,938 | 17,257 |
| Change In Receivables | 8,843 | -14,439 | -10,764 | 799.00 |
| Change In Payables And Accrued Expense | 75,135 | 18,238 | -967.00 | 16,458 |
| Change In Payable | 75,135 | 18,238 | -967.00 | 16,458 |
| Other Non Cash Items | -- | -- | -35,248 | 0.00 |
| Capital Expenditure | -9,740 | -56,737 | -- | -- |
| Purchase Of PPE | -9,740 | -56,737 | 2,739 | 0.00 |
| Net PPE Purchase And Sale | -9,740 | -56,737 | 2,739 | 16,667 |
| Investing Cash Flow | -9,740 | -56,737 | 2,739 | 16,667 |
| Cash Flow From Continuing Investing Activities | -9,740 | -56,737 | 2,739 | 16,667 |
| Issuance Of Capital Stock | -- | -- | 204,000 | 70,200 |
| Net Common Stock Issuance | -- | -- | 204,000 | 70,200 |
| Financing Cash Flow | -- | -- | 166,805 | 60,880 |
| Cash Flow From Continuing Financing Activities | -- | -- | 166,805 | 60,880 |
| Changes In Cash | 420,590 | -98,741 | 82,575 | 70,709 |
| Beginning Cash Position | 56,271 | 155,012 | 72,437 | 1,728 |
| End Cash Position | 476,861 | 56,271 | 155,012 | 72,437 |
| Free Cash Flow | -58,307 | -98,741 | -84,230 | -6,838 |
| Change In Account Payable | 74,452 | 17,532 | -1,664 | 15,752 |
| Change In Prepaid Assets | -19,333 | 5,747 | -13,207 | 0.00 |
| Common Stock Issuance | -- | -- | 204,000 | 70,200 |
| Net Income From Continuing Operations | -100,942 | -142,905 | -27,798 | -24,095 |
| Net Other Financing Charges | -- | -- | -37,195 | -- |
| Sale Of PPE | -- | -- | 0.00 | -- |
| Unrealized Gain Loss On Investment Securities | -3,325 | -1,045 | 1,015 | 0.00 |